Evelo Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- November 04, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $35,000,000
Company Info
- Founding Year
- 2015
- Founders
- Simba Gill
- Company Description
- Evelo Therapeutics is dedicated to transforming cancer therapy through a deep understanding of the cancer microbiome. Evelo is discovering and developing Oncobiotic™ therapies, novel treatments designed to attack cancer by disrupting the microbial environment which supports tumors and protects them from the body's immune system.
- Market
- Cancer Therapy
- Location
- Cambridge, MA, USA